SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-22-001241
Filing Date
2022-06-14
Accepted
2022-06-14 12:55:37
Documents
17
Period of Report
2022-06-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bdpt_8k.htm   iXBRL 8-K 19432
2 PRESS RELEASE bdpt_ex991.htm EX-99.1 9088
3 PRESS RELEASE bdpt_ex992.htm EX-99.2 12662
9 bdpt_8kimg1.jpg GRAPHIC 5413
  Complete submission text file 0001640334-22-001241.txt   178747

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20220609.xsd EX-101.SCH 5854
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20220609_lab.xml EX-101.LAB 13255
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20220609_cal.xml EX-101.CAL 914
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20220609_pre.xml EX-101.PRE 8349
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20220609_def.xml EX-101.DEF 2119
11 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_8k_htm.xml XML 3279
Mailing Address 1015 S CIMARRON RD LAS VEGAS NV 89145
Business Address 1015 S CIMARRON RD LAS VEGAS NV 89145 (702) 560-1632
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

IRS No.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54949 | Film No.: 221014021
SIC: 2834 Pharmaceutical Preparations